Mila to Millions: A New Era of Individualized Medicines
By Julia Vitarello
By Julia Vitarello
Accord Healthcare limited is recalling a single batch due to an out of specification test result.
Updated product information for healthcare professionals and patients regarding the small risk of severe acute pancreatitis in patients taking GLP-1s.
Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients.
Batches of quetiapine oral suspension from Eaststone Limited are being recalled due to the active content being twice the amount it should be. Patients should not stop taking this medicine without consulting their healthcare professional.
Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle.
List of Field Safety Notices from 19 to 23 January 2026.
Summary of the latest safety advice for medicines and medical device users
Marketing authorisations Granted in 2026.
Parallel import licences granted in 2026.
New online resources will help the public, parents, carers and health, social care and education professionals understand what safe, effective digital mental health technologies look like in practice.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.